In a network analysis, these genes were part of insulin signaling, chemokine and cytokine signaling and extracellular matrix pathways.
These genetic discoveries implicate the role of the collagen and extracellular matrix pathways in the regulation of CCT [ 207] and potentially KC.
Correlated assays were enriched in cytokine and extracellular matrix pathways.
The integration of the functional analysis results for the 162 immobilization-only genes revealed enrichment of genes involved in lipid synthesis and extracellular matrix pathways.
Commercial 96-well plate arrays for the focal adhesion and extracellular matrix pathways were also assayed for each MEF genotype (SABiosciences, Frederick, MD).
In our analysis, overlapping genes were part of insulin signaling, chemokine and cytokine signaling as well as extracellular matrix pathways.
A recent meta-analysis of GWAS discovered at least 19 genes and associated cellular pathways for AMD pathogenesis; these included the complement system (CFH, C2/ CFB, C3 and CFI), the high-density lipoprotein pathway (LIPC and CETP), the extracellular or collagen matrix pathway (TIMP3, COL8A1and COL10and and the angiogenesis signaling pathway (VEGFA) [ 10].
There is a large matrix of pathways and brain areas that work together to influence the pain experience.
Together, these findings suggest that dysregulation of miR-146a may contribute to OA pathogenesis by inhibiting Smad4, a key component in the anabolic TGF-β pathway, by stimulating VEGF in the angiogenesis, chondrocyte hypertrophy, and extracellular matrix degradation pathways, and by inducing chondrocyte death.
Identifying several genetic loci revealed that several important biological pathways are involved in AMD pathogenesis, such as the cholesterol, lipid metabolism pathway, complement pathway, extracellular matrix pathway, oxidative stress pathway, and angiogenesis signaling pathway in [ 20– 22], which provides a foundation for systematically analyzing the biological processes underlying AMD.
